LAVAL, QC, Oct. 31 /CNW Telbec/ - LAB Research Inc. ("LRI" or "LAB
Research") (TSX: LRI), a Canadian-based global non-clinical contract research
organization, is pleased to announce the appointment of Chris Banks as its new
Managing Director for its recently expanded Hungarian operations. In addition,
LAB Research also announces that Alyson Leyshon will be joining LAB Research
Hungary as Director of Toxicology Operations. Both appointments will be
effective in January 2008.
"We are delighted to welcome Chris Banks to LAB Research. Chris has the
perfect profile to take over the Managing Director's role in Hungary as we
continue to invest in staff and facilities to expand our toxicology
capabilities in Europe." said Mr. Luc Mainville, President and Chief Executive
Officer of LAB Research. "The hiring of Chris and Alyson in Hungary
significantly enhances our ability to serve an ever-widening client base in
Europe, North America and Asia. In addition to regulatory planning and program
development experience that will benefit our customers, they will be
contributing with their expertise and experience in managing toxicological
Mr. Mainville further commented "The appointment of Mr. Banks and
Ms. Leyshon will contribute to the growth of LRI's facility in Hungary, where
the large animal housing capabilities of the site increased five-fold as of
September of this year. The strengthening of our management and scientific
staff in Hungary is a direct evidence of our commitment to keep building our
global platform which promotes excellence in research" concluded
Following these appointments, Dr. Gabor Hirka, the current site manager
will remain with the company but will be assuming different responsibilities.
Christopher Martin Banks
Chris Banks is a Diplomat of the American Board of Toxicology. His career
has spanned three decades in contract research. He worked twelve years with
LSR (now Huntingdon Life Science), prior to spending nineteen years in Canada
with Charles River Laboratories ("CRL" formerly CTBR and Bio-Research). Most
recently, he was responsible for the oversight and coordination of drug
development programs for current or future key clients of CRL Canada.
Alyson Leyshon has a background in Toxicology, Biochemistry and Genetics.
She amassed fifteen years of experience in contract research in the UK and
Canada. Alyson started her CRO career at Covance in the UK, worked as Director
of Scientific Operations with CRL Canada and was most recently acting as a
consultant to a Canadian based CRO.
About LAB Research Inc.
LAB Research is a global non-clinical contract research organization that
provides contract research services to the pharmaceutical, biotechnology,
agro-chemical, petro-chemical and industrial markets. LAB Research supports
the development of its customers' products from three state-of-the-art
facilities located in Canada, Denmark and Hungary. LAB Research's shares trade
on the TSX under the symbol "LRI", with 18.0 million shares outstanding.
For further information:
For further information: Luc Mainville, Chief Executive Officer, LAB
Research Inc., (450) 973-2240, Ext.: 1206, firstname.lastname@example.org; Media
and Investor Relations: Dominic Sicotte, Echoes Financial Network Inc.,
1-866-633-9551, (514) 842-9551, email@example.com